Showing posts with label MAY. Show all posts
Showing posts with label MAY. Show all posts

Tuesday, 30 May 2017

HANDSHAKES MAY ENGAGE OUR SENSE OF SMELL




Why do people shake hands? A new Weizmann Institute study suggests one of the reasons for this ancient custom may be to check out each other's odors. Even if we are not consciously aware of this, handshaking may provide people with a socially acceptable way of communicating via the sense of smell
Not only do people often sniff their own hands, but they do so for a much longer time after shaking someone else's hand, the study has found. As reported today in the journal eLife, the number of seconds the subjects spent sniffing their own right hand more than doubled after an experimenter greeted them with a handshake.
"Our findings suggest that people are not just passively exposed to socially-significant chemical signals, but actively seek them out," said Idan Frumin, the research student who conducted the study under the guidance of Prof. Noam Sobel of Weizmann's Neurobiology Department. "Rodents, dogs and other mammals commonly sniff themselves, and they sniff one another in social interactions, and it seems that in the course of evolution, humans have retained this practice -- only on a subliminal level."
To examine whether handshakes indeed transfer body odors, the researchers first had experimenters wearing gloves shake the subjects' bare hands, then tested the glove for smell residues. They found that a handshake alone was sufficient for the transfer of several odors known to serve as meaningful chemical signals in mammals. "It's well known that germs can be passed on through skin contact in handshakes, but we've shown that potential chemical messages, known as chemosignals, can be passed on in the same manner," Frumin says.
Next, to explore the potential role of handshakes in communicating odors, the scientists used covert cameras to film some 280 volunteers before and after they were greeted by an experimenter, who either shook their hand or didn't. The researchers found that after shaking hands with an experimenter of the same gender, subjects more than doubled the time they later spent sniffing their own right hand (the shaking one). In contrast, after shaking hands with an experimenter of the opposite gender, subjects increased the sniffing of their own left hand (the non-shaking one). "The sense of smell plays a particularly important role in interactions within gender, not only across gender as commonly assumed," Frumin says.
The scientists then performed a series of tests to make sure the hand-sniffing indeed served the purpose of checking out odors and was not merely a stress-related response to a strange situation. First, they measured nasal airflow during the task and found that subjects were truly sniffing their hands and not just lifting them to their nose. It turned out that the amount of air inhaled by the volunteers through the nose doubled when they brought their hands to their face. Next, the scientists found they could manipulate the hand-sniffing by artificially introducing different smells into the experimental setting. For example, when experimenters were tainted with a commercial unisex perfume, the hand-sniffing increased. In contrast, when the experimenters were tainted with odors derived from sex hormones, the sniffing decreased. These final tests confirmed the olfactory nature of the hand-sniffing behavior.
Taking part in the study were Ofer Perl, Yaara Endevelt-Shapira, Ami Eisen, Neetai Eshel, Iris Heller, Maya Shemesh, Aharon Ravia, Dr. Lee Sela and Dr. Anat Arzi, all of Prof. Sobel's lab
"Handshakes vary in strength, duration and posture, so they convey social information of various sorts," says Prof. Sobel. "But our findings suggest that at its evolutionary origins, handshaking might have also served to convey odor signals, and such signaling may still be a meaningful, albeit subliminal, component of this custom."


Tuesday, 16 May 2017

EXPOSURE IN ALUMINIUM MAY IMPACT ON MALE FERTILITY




New research from scientists in the UK and France suggests that human exposure to aluminum may be a significant factor in falling sperm counts and reduced male fertility.
Fluorescence microscopy using an aluminum-specific stain confirmed the presence of aluminum in semen and showed aluminum inside individual sperm.
And the team of scientists, at the universities of Lyon and Saint-Etienne in France and Keele in the UK, found that the higher the aluminum, the lower sperm count.
The research, led by Professor Christopher Exley, a leading authority on human exposure to aluminum at Keele, and Professor Michele Cottier, a specialist in cytology and histology at Saint-Etienne, measured the aluminum content of semen from 62 donors at a French clinic.
Professor Exley said: "There has been a significant decline in male fertility, including sperm count, throughout the developed world over the past several decades and previous research has linked this to environmental factors such as endocrine disruptors.
"Human exposure to aluminum has increased significantly over the same time period and our observation of significant contamination of male semen by aluminum must implicate aluminum as a potential contributor to these changes in reproductive fertility."
The mean aluminum content for all 62 donors was found to be very high at 339 ppb with the aluminum content of semen from several donors being in excess of 500 ppb. A statistically significant inverse relationship was found between the aluminum content of semen and the sperm count. Higher aluminum resulted in a lower sperm count.



Thursday, 4 May 2017

How They May Diagnose Your Neuropathy


Following on from yesterday's video, today's post from aboutperipheralneuropathy.blogspot.com (see link below) is the text attached to the video and gives a much more detailed explanation of neuropathy testing and diagnosis. Sadly, many neuropathy patients never get to the MRI, skin biopsy stage of testing because either their doctors feel they have enough information from the patient's own account, or there is pressure from financial authorities not to 'indulge' in very expensive testing procedures. It is true that in many cases, the patient's own experiences, coupled with an obvious cause for their neuropathy (diabetes, HIV, cancer treatment etc) mean that further testing is unnecessary - it's quite clear what the problem is and the treatment is generally not influenced by further extensive testing. An interesting breakdown of neuropathy diagnosis.


How to diagnose peripheral neuropathy 
Monday, 2 September 2013

Nervous system

Peripheral neuropathy is characterized by damage to nerves of the peripheral nervous system (nerves outside the brain and the spinal cord). It compasses a wide range of disorders.

Diagnosing peripheral neuropathy is a challenge to the medical profession. It is not easy because the symptoms are highly variable. Diagnosis usually involves a thorough neurological examination.

Diagnosis of peripheral neuropathy involves extensive analysis of patient history. This includes patient’s work environment, various symptoms, social habits, exposure to toxins, risk of HIV, history of alcoholism, risk of various infectious diseases and family history of nerve related medical conditions.

Doctors perform tests in order to identify the cause of neuropathic disorder. They conduct tests to determine the extent of nerve damage. Tests are also conducted to determine the type of nerve damage.

Presence of a systemic medical condition (something that is affecting the entire system) is revealed by general physical examination and related tests. Liver dysfunction, diabetes, vitamin deficiencies, kidney dysfunction and signs of abnormal immune system activity are detected by blood test.

Examination of cerebrospinal fluid that surrounds the brain and the spinal cord reveals abnormal antibodies associated with neuropathy. Specialized tests reveal cardiovascular disorders, blood related medical conditions, connective tissue disorders or malignancies.

Motor fiber involvement may be determined by testing muscle strength and by checking for evidence of cramps or fasciculations (muscle twitches). Muscle twitch is a small, local, involuntary muscle contraction and relaxation which is usually visible under the skin.

Sensory nerve damage can be identified by evaluating the patient’s ability to register light touch, pain, vibration, body position and temperature. This evaluation also indicates whether small or large sensory nerve fibers are affected.

Doctors may recommend additional tests based on the results of the neurological examination, patient history, physical examination and any pervious testing or screening. It depends on the patient’s overall condition. Additional tests help to determine the nature and extent of neuropathy.

MRI

Magnetic resonance imaging (MRI) is used to examine muscle size and quality. It can also detect any fatty replacement of muscle tissue. MRI can determine whether a nerve fiber has sustained compression damage.





MRI uses a magnetic field and pulses of radio wave energy. It reveals problems that cannot be seen with other imaging methods. During an MRI test, the area of the body being studied is placed inside a special equipment that contains a strong magnet.

The high-tech MRI equipment creates a strong magnetic field around the body. Radio waves are passed through the body in order to trigger a resonance signal that can be detected at different angles inside the body.

A computer processes this resonance into either a 2D slice or a 3D image of the scanned area. Images from an MRI scan are digital images that can be stored on a computer for further study.

Another advantage of MRI is that the images generated with the help of the test can be reviewed remotely, such as in an operating room or in a clinic. Contrast material is used in some cases to show certain structures more clearly.

NCV

Nerve conduction velocity (NCV) tests are used to precisely measure the degree of damage in larger nerve fibers. They reveal whether symptoms are being caused by degeneration of the axon or the myelin sheath.

Patches known as surface electrodes (similar to those used for ECG) are placed on the skin over nerves at various locations. Each patch gives a mild electrical impulse which stimulates the nerve.

The nerve fiber responds by generating its own electrical impulse. An electrode placed further along the nerve’s pathway measures the speed of impulse transmission along the axon (nerve fiber).

Impulse blockage and slow transmission rates tend to indicate damage to the myelin sheath (a fatty, axon-enwrapping sheath). Reduction in strength of impulses is a sign of axonal degeneration.

To prepare for the test, normal body temperature needs to be maintained. This is because low body temperature slows nerve conduction. It is very important to take appropriate precautions before performing this test on patients with pacemaker or cardiac defribrillator.

During the NCV test, the patient may feel the impulse like an electric shock. It may be uncomfortable to some people. However, there will be no pain after the test is finished. This is the experience of many people on whom this test is performed.

CT scan

CT scan stands for computed tomography scan. It is also known as CAT (computer axial tomography) scan. It is a noninvasive process that employs tomography. Tomography is the process of generating a 2D image of a slice or section through at 3D object (a tomogram).





This medical imaging method is used to produce rapid, clear, 2D images of bones, organs and tissues. CT scan is a painless process. The machine used is knows as CTG scanner. It uses X-rays. X-rays are passed through the body at various angles and are detected by a computerized scanner.

The data that is generated is processed and displayed as cross-sectional images of the internal structure of the body or of a particular organ. These images are also known as slices.

Neurological CT scans detect vascular or bone irregularities, some brain tumors and cysts, encephalitis, herniated disks, spinal stenosis and other disorders. Spinal stenosis is characterized by narrowing of the spinal canal.

EMG

Electromyography (EMG) is a process wherein a fine needle is inserted into a muscle in order to compare the amount of electrical activity present when muscles are at rest and when they contract. EMG helps differentiate between nerve and muscle disorders.

Nerve biopsy

Biopsy is a medical test usually performed by a surgeon or an interventional radiologist. It involves sampling of cells or tissues for examination. It is the removal of tissue form a living object in order to determine the extent or presence of a medical condition.

Nerve biopsy is an invasive procedure involves removing and examining a sample of nerve tissues. Nerve tissues are usually removed from the lower leg. This test can provide valuable information regarding the degree of nerve damage.

Nerve biopsy is an invasive procedure. It is not easy to perform. In some cases, this procedure may itself cause neuropathic side effects. According to experts, nerve biopsy is not always needed for diagnosis.

Skin biopsy


Skin biopsy is a biopsy technique in which doctors remove a thin skin sample and examine nerve fiber endings. This test offers some unique advantages over NCV tests and nerve biopsy.

Unlike NCV, skin biopsy reveals damage present in small fibers. Skin biopsy is less invasive than nerve biopsy. It is also easier to perform. Skin biopsy has lesser side effects than nerve biopsy.

The above-mentioned techniques help doctors diagnose peripheral neuropathy effectively. Right diagnosis enables them to work for improvement in the overall quality of the patient’s life.

Doctors can work with patients affected by peripheralneuropathy and add value to their overall well-being. For this to be possible, patients should keep up their appointments with their doctor. Peripheral neuropathy should not be neglected.

http://aboutperipheralneuropathy.blogspot.com/2013/09/how-to-diagnose-peripheral-neuropathy.html

Friday, 14 April 2017

BARIATRIC SURGERY MAY WORSEN DEPRESSION FOR SOME



Most obese people feel better after weight-loss surgery but unfortunately, this is not true for some, says a study.
Symptoms of depression worsened for many patients when the levels of depression in patients were measured six to 12 months after they have had bariatric surgery, the findings showed.
For the study, the researchers set out to investigate if depressive symptoms increase markedly or not at all, after post-surgery.
The study involved 107 patients with extreme obesity.
Consistent with previous research, the researchers observed that most people who had undergone this procedure were in much better spirits.
However, in some cases negative mood changes started to creep in between six and 12 months after the operation, with 3.7 percent of patients reporting that they felt discernibly more depressed 12 months post-surgery.

Between six and 12 months after the operation, however, even more patients (13.1 percent) reported increases in depressive symptoms.
These changes went hand-in-hand with significantly lower levels of self-esteem and social functioning.
“The majority of patients whose mood had worsened discernibly experienced these mood changes between six and 12 months post-surgery, suggesting this may be a critical period for early detection and intervention, as needed,” explained Valentina Ivezaj from Yale University School of Medicine in the US.
“The increases in symptoms of depression are also notable given that they were associated with other difficulties including lower self-esteem and social functioning,” Carlos Grilo from Yale University School of Medicine in the US added.
The study appeared in the journal Obesity Surgery.

Tuesday, 28 March 2017

New Drug Development May End Up Replacing Morphine


Today's post from sciencedaily.com (see link below) is an interesting new development in finding effective ways to block pain signals for people like neuropathy and cancer sufferers. New research has discovered new compounds which bind to specific molecules (opioid receptors) on nerve cells. Opioids do this already but we all know the dangers of opioids and addiction and the need for ever increasing dosages. These new compounds attach themselves to a different part of the nerve cell but work in the same way without the normal opioid side effects. That's the theory anyway and as with many of these promising developments, sometimes you wish they wouldn't tell us about them until they're almost in production. Getting patients' hopes up but then letting them wait for years can be demoralising in itself. However, it does sound very promising and this is an easy to read article even though it's looking at the science at a molecular level.

A Path to Lower-Risk Painkillers: Newly-Discovered Drug Target Paves Way for Alternatives to Morphine
This story is reprinted from materials provided by University of Michigan Health System June 10, 2013

 For patients managing cancer and other chronic health issues, painkillers such as morphine and Vicodin are often essential for pain relief. The body's natural tendency to develop tolerance to these medications, however, often requires patients to take higher doses -- increasing risks of harmful side effects and dependency.

Now, new research from the University of Michigan Health System and a major pharmaceutical company has identified a novel approach to moderate and severe pain therapy that paves the way for lower dosage painkillers. The findings appear in Proceedings of the National Academy of Sciences.

Drugs such as hydrocodone (the main ingredient of Vicodin) and oxycodone (Oxycontin) are often the best options for the treatment of moderate to severe pain for patients facing medical conditions ranging from a wisdom tooth extraction to cancer. The drugs bind to specific molecules (opioid receptors) on nerve cells in the brain and spinal cord to prevent the feeling of pain.

"We have for the first time discovered compounds that bind to an alternative site on the nerve opioid receptors and that have significant potential to enhance the drug's positive impact without increasing negative side effects," says co-author John Traynor, Ph.D., professor of pharmacology at the U-M Medical School.

"We are still in the very early stages of this research with a long way to go, but we believe identifying these compounds is a key step in revolutionizing the treatment of pain. This opens the door to developing pain relief medications that require lower doses to be effective, helping address the serious issues of tolerance and dependence that we see with conventional pain therapy."

Conventional drug treatments for pain work by targeting the so-called orthosteric site of the opioid receptor that provides pain relief. Targeting this site, however, is a double-edged sword because it is also responsible for all of the drug's unwanted side effects, such as constipation and respiratory depression. Tolerance also limits chronic use of the drugs because higher doses are required to maintain the same effect.

Using cell systems and mouse brain membranes, researchers have identified compounds that bind to a physically distinct and previously unknown "allosteric" site on the opioid receptor- a site that fine-tunes the activity of the receptor. Not only do these compounds act at a location that hasn't been studied as a drug target before but they bind to the receptor in a new way to enhance the actions of morphine -- which means lower doses can have the same impact.

"The newly-discovered compounds bind to the same receptor as morphine but appear to act at a separate novel site on the receptor and therefore can produce different effects. What's particularly exciting is that these compounds could potentially work with the body's own natural painkillers to manage pain," Traynor says.

"We know that conventional strong pain medications ultimately increase the risk of withdrawal symptoms and addiction, which is an especially serious issue with the current prescription drug abuse epidemic in our country. The implications of this work, if it translates to animal studies and then to humans, are highly significant to this area of study."

http://www.sciencedaily.com/releases/2013/06/130610192553.htm

Thursday, 16 February 2017

SEVERE PNEUMONIA MAY PERMANENTLY DAMAGE HEART



Severe pneumonia may permanently damage your heart as pneumonia bacterium leaves tiny lesions in the heart, a study suggests.
The researchers found proof that Streptococcus pneumoniae, the leading cause of community-acquired pneumonia, actually physically damages the heart.
The researchers detected tiny lesions that the bacterium leaves in mouse, rhesus macaque and human autopsy tissue samples.
"If you have had severe pneumonia, this finding suggests your heart might be permanently scarred," said study senior author Carlos Orihuela, associate professor of microbiology and immunology at The University of Texas Health Science Center at San Antonio, US.
Streptococcus pneumoniae in the blood invaded the heart and formed lesions in the myocardium, the muscular middle layer of the heart wall, the researchers showed.
The team identified mechanisms by which the bacterium is able to spread across endothelial cells in cardiac blood vessels to travel to and infect the heart.
"Fortunately, we have a candidate vaccine that can protect against this," Orihuela noted.
The candidate vaccine acts to stop both the movement of the infection into the heart and the toxin that kills heart muscle cells called cardiomyocytes.
The vaccine protected immunized animals against cardiac lesion formation, the study showed.
The study appeared in the journal PLoS Pathogen



Sunday, 8 January 2017

AN AVOCADO A DAY MAY HELP KEEP BAD CHOLESTEROL AT BAY


Eating one avocado a day as part of a heart healthy, cholesterol-lowering moderate-fat diet can help improve bad cholesterol levels in overweight and obese individuals, according to new research published in theJournal of the American Heart Association.

Researchers evaluated the effect avocados had on traditional and novel cardiovascular risk factors by replacing saturated fatty acids from an average American diet with unsaturated fatty acids from avocados.
Forty-five healthy, overweight or obese patients between the ages of 21 and 70 were put on three different cholesterol-lowering diets. Participants consumed an average American diet (consisting of 34 percent of calories from fat, 51 percent carbohydrates, and 16 percent protein) for two weeks prior to starting one of the following cholesterol lowering diets: lower fat diet without avocado, moderate-fat diet without avocado, and moderate-fat diet with one avocado per day. The two moderate fat diets both provided 34 percent of calories as fat (17 percent of calories from monounsaturated fatty acids/MUFAs), whereas the lower fat diet provided 24 percent of calories as fat (11 percent from MUFAs). Each participant consumed each of the three test diet for five weeks. Participants were randomly sequenced through each of the three diets.
Researchers found:
·         Compared to the baseline average American diet, low-density lipoprotein (LDL) -- the so called 'bad cholesterol' -- was 13.5 mg/dL lower after consuming the moderate fat diet that included an avocado. LDL was also lower on the moderate fat diet without the avocado (8.3 mg/dL lower) and the lower fat diet (7.4 mg/dL lower), though the results were not as striking as the avocado diet.
·         Several additional blood measurements were also more favorable after the avocado diet versus the other two cholesterol-lowering diets as well: total cholesterol, triglycerides, small dense LDL, non-HDL cholesterol, and others.
These measurements are all considered to be cardio-metabolic risk factors in ways that are independent of the heart-healthy fatty acid effects, said Penny M. Kris-Etherton, Ph.D., R.D., senior study author and Chair of the American Heart Association's Nutrition Committee and Distinguished Professor of Nutrition at Pennsylvania State University, in University Park, Pennsylvania.
"This was a controlled feeding study, but that is not the real-world -- so it is a proof-of-concept investigation. We need to focus on getting people to eat a heart-healthy diet that includes avocados and other nutrient-rich food sources of better fats," Kris-Etherton said.
"In the United States avocados are not a mainstream food yet, and they can be expensive, especially at certain times of the year. Also, most people do not really know how to incorporate them in their diet except for making guacamole. But guacamole is typically eaten with corn chips, which are high in calories and sodium. Avocados, however, can also be eaten with salads, vegetables, sandwiches, lean protein foods (like chicken or fish) or even whole."
For the study researchers used Hass avocados, the ones with bumpy green skin. In addition to MUFAs, avocados also provided other bioactive components that could have contributed to the findings such as fiber, phytosterols, and other compounds.
According to researchers, many heart-healthy diets recommend replacing saturated fatty acids with MUFAs or polyunsaturated fatty acids to reduce the risk of heart disease. This is because saturated fats can increase bad cholesterol levels and raise the risk of cardiovascular disease.
The Mediterranean diet, includes fruits, vegetables, whole grains, fatty fish, and foods rich in monounsaturated fatty acids--like extra-virgin olive oil and nuts. Like avocados, some research indicates that these not only contain better fats but also certain micronutrients and bioactive components that may play an important role in reducing risk of heart disease.


Thursday, 20 October 2016

Blocking Calcium Channels May Help With Neuropathic Pain


Today's post from themayerinstitute.ca (see link below) talks about how neuropathic pain and other symptoms can be helped by blocking calcium channels with certain drugs. It is directed (as so many are) at diabetes patients who end up with neuropathy as a result of glucose imbalance but although diabetes is by far the most common cause of neuropathy, the treatments are very much the same whatever the cause. If you're an experienced neuropathy patient, you may have heard that many drugs block sodium channels to achieve the same result; this treatment is an alternative and claims to work on the nerves rather than the brain although which specific treatment they are talking about is not mentioned. Many neuropathy treatments involve taking anti-depressants or anti-convulsants and these act on these channels in the brain so whether this medication is in the same family or not is unclear. If one of the side effects is that it makes patients sleepy then it is clearly having an effect on nerve cells in the brain anyway. 



Reversing Painful Diabetic Neuropathy: Blocking the calcium channel floodgates may be the answer.
August 27, 2013

This article originally posted 22 August, 2013 and appeared in Neuropathy, Issue 691


Discovery Shows the Way to Reverse Diabetic Nerve Pain


New information on one of diabetes' most debilitating complications….

Diabetic neuropathy affects approximately 60-70% of people with diabetes. For such a common problem that affects patients with diabetes, little is known about peripheral neuropathy. Patients with diabetes who are suffering from peripheral neuropathy talk of how terrible it is to live with the condition: how a gentle touch can be agonizing and how a warm shower can be torturous. But, at the University of Virginia School of Medicine, new research has shed some more light on peripheral neuropathy's causes and may eventually suggest a way to reverse it.

"Normally pain is useful information because it alerts us that there is a damaging effect – something happening to tissues. But this pain is typically without any obvious reason," UVA researcher and anesthesiologist Dr. Slobodan M. Todorovic explains. "It's because nerves are being affected by high levels of glucose in the blood. So nerves start working on their own and start sending pain signals to the brain. It can be a debilitating condition that severely affects quality of life."

Dr. Slobodan Todorovic and Dr. Vesna Jevtoviv-Todorovic, Harold Carron Professor of Anethesiology and Neuroscience at UVA, have demonstrated the reversal of peripheral diabetic neuropathy in mice through the use of a substance that is naturally present in both humans and animals.

The researchers and their colleagues discovered that the high levels of blood sugar cause a change to the structure of channels that allow for the release of calcium into the nerve cells. This in effect forces them open and the overload of calcium into the cells causes them to become hyperactive. This high level of activity can lead to various effects, such as a slight tingling in the arms and legs or an excruciating pain.

Knowing this may prove to extremely important not only in the treatment of diabetic neuropathy, but in other conditions such as nerve injury from an accident, a wound received in combat or other causes for chronic pain. Dr. Todorovic stated that he and his research team found that the function of these calcium channels is similarly affected in these conditions.

The Todorovics said that finding more treatment options for diabetic neuropathy is very important because of the increasing prevalence of diabetes and the lack oftherapeutic options. They go on to say that a commonly used drug was helpful for some but not all patients, often times causing considerable fatigue.

"A lot of patients decide to cope with the pain rather than to be sleepy all day," Todorovic said. However, the substance the University of Virginia researchers are testing in their study does not cause drowsiness. This is due to the fact that it works on the nerves rather than in the brain. "In some ways, you can think about it as going back to the baseline," Jevtovic-Todorovic said. "It's not a complete blockade; it’s a normalization."

The new findings have been published online by the journal Diabetes and will appear in a forthcoming print edition. The UVA researchers hope that reversing the early stages of diabetic neuropathy could prevent the complete loss of feeling associated with the advanced stages of the disease.

University of Virginia Press Release

http://www.themayerinstitute.ca/reversing-painful-diabetic-neuropathy-blocking-the-calcium-channel-floodgates-may-be-the-answer/

Tuesday, 4 October 2016

Peruvian Green Velvet Tarantula May Kill Pain Too


Today's post from sciencedaily.com (see link below) revisits an area of research that seems to have been relatively quiet recently and that is the potential for animal venoms to create pain killers. This time, the article talks about Tarantula spider toxins and in particular the exotic sounding, Peruvian green velvet tarantula. Apparently this creature's venom can selectively inhibit pain receptors and as such, when refined, has great potential as a future pain killer, especially for nerve pain. When you think that the spider's purpose is to paralyse its prey so that there's no struggle and easy eating, then the stretch of our imagination may not be so great. The article becomes more complex as it goes on but you will get the gist and we can once again be excited by the potential of snake, spider and fish venoms to help relieve our neuropathy symptoms. The sooner it can be put into a bottle, the sooner we won't be confronted by images of its donor!

Tarantula toxins converted to painkillers
Date:February 29, 2016Source:Biophysical Society  

 
It turns out that peptide toxins isolated from the venom of some animals -- such as the Peruvian green velvet tarantula -- can be beneficial when used to target neural receptors to reduce the sensation of pain.

When venom from animals such as spiders, snakes or cone snails is injected via a bite or harpoon, the cocktail of toxins delivered to its victim tends to cause serious reactions that, if untreated, can be lethal. But even venom has a therapeutic upside: Individual peptide toxins are being tapped to target receptors in the brain to potentially serve as painkillers.

Millions of people live with chronic and neuropathic pain, in large part because current treatments often provide limited pain relief, have a heavy profile of soporific side effects and can be extremely addictive. So researchers around the globe are chasing down potential new therapeutic agents and working to gain a better understanding of how molecules with painkiller activity function. This will lead to alternative painkillers--and possibly improve the quality of life for people who suffer from chronic pain.

At the Biophysical Society's 60th Annual Meeting, being held in Los Angeles, Calif., Feb. 27-March 2, 2016, a group of researchers from the University of Queensland in Brisbane, Australia, will describe their efforts with ProTx-II, a peptide toxin found within the venom of the Peruvian green velvet tarantula, Thrixopelma pruriens. Its high potency and selectivity to inhibit the pain sensation receptor make it an ideal candidate as a future painkiller.

"Our group is specifically interested in understanding the mode of action of this toxin to gain information that can guide us in the design and optimization of novel pain therapeutics," said Sónia Troeira Henriques, senior research officer at the University of Queensland's Institute for Molecular Bioscience.

How does ProTx-II work? "It binds to the pain receptor located within the membrane of neuronal cells, but the precise peptide-receptor binding site and the importance of the cell membrane in the inhibitory activity of ProTx-II is unknown," explained Henriques.

So the group zeroed in on its structure-activity relationship by "exploring the structure, the membrane-binding properties, and the inhibitory activity of ProTx-II and a series of analogues," she added.

Nuclear magnetic resonance (NMR) spectroscopy enables 3-D characterization of the structure of this peptide, which allows the group to explore whether it's important for its ability to inhibit the pain receptor.

They also use surface plasmon resonance and fluorescence methodologies, as well as molecular simulations, to further characterize the interactions between the peptide and the neuronal cell membrane and to identify the molecular properties of the peptide involved in the interaction and inhibition with the pain receptor.

"Our results show that the cell membrane plays an important role in the ability of ProTx-II to inhibit the pain receptor. In particular, the neuronal cell membranes attract the peptide to the neurons, increase its concentration close to the pain receptors, and lock the peptide in the right orientation to maximize its interaction with the target," said Henriques.

The group's work is the first to describe the importance of the membrane-binding properties of ProTx-II for its potency as an inhibitor of Nav 1.7, an important pain receptor. "Until now, studies characterizing the inhibitory activity of venom toxins have ignored the potential role of the cell membrane in their potency and activity," she noted.

Beyond Nav 1.7, "other voltage-gated ion channels are located at the cell membrane and involved in a range of physiological processes such as muscle and nerve relaxation, regulation of blood pressure, and sensory transduction," Henriques pointed out. "Their 'faulty' activity is, however, associated with several disorders, so other ion channels are actively being pursued as drug targets for the treatment of neuromuscular disease, neurological disorders, and inflammatory and neuropathic pain."

Based on the group's findings, they're now designing new toxins with greater affinity for the cell membrane and fewer side effects.

"Our work creates an opportunity to explore the importance of the cell membrane in the activity of peptide toxins that target other voltage-gated ion channels involved in important disorders," said Henriques.

Story Source:

The above post is reprinted from materials provided by Biophysical Society. Note: Materials may be edited for content and length.


 https://www.sciencedaily.com/releases/2016/02/160229082005.htm

Tuesday, 5 July 2016

CHOLESTEROL DRUG MAY BENEFIT DIABETIC WOMEN



Australian researchers have found that a cholesterol-lowering drug can lower cardiovascular disease risks by 30 percent in women with type-2 diabetes.
The five-year study of nearly 10,000 people with type-2 diabetes also assessed the drug fenofibrate’s impact on a range of lipoproteins and triglycerides (circulating blood fats) that elevate the risk of cardiovascular events such as stroke and heart attack.
They found that among type-2 diabetic patients with an elevated risk of cardiovascular disease, fenofibrate cut adverse cardiovascular outcomes by 30 percent in women and 24 percent in men.
“The finding is good news for women. The study shows that fenofibrate reduced the risk of dying from cardiovascular disease, or having a stroke or other adverse cardiovascular event more in women,” said Tony Keech from University of Sydney.
Fenofibrate stimulates the action of an enzyme that breaks down triglycerides and low-density lipoproteins.
Stimulating this enzyme increases the breakdown of triglycerides (another type of blood lipid) and low-density lipoproteins in the bloodstream and raises HDL cholesterol.
“Cardiovascular disease is the most common cause of death in women, almost three times more common than breast cancer,” said study’s lead author Michael d’Emden from Royal Brisbane Hospital.
The study appeared in the journal Diabetologia

Thursday, 23 June 2016

HIGH DENSITY SOUND WAVES MAY AID REGENERATIVE MEDICINE


Researchers at the University of Washington have developed a way to use sound to create cellular scaffolding for tissue engineering, a unique approach that could help overcome one of regenerative medicine's significant obstacles. The researchers will present their technique at the 168th meeting of the Acoustical Society of America (ASA), held October 27-31, 2014, at the Indianapolis Marriott Downtown Hotel.
The development of the new technique started with somewhat of a serendipitous discovery. The University of Washington team had been studying boiling histotripsy -- a technique that uses millisecond-long bursts of high-intensity ultrasound waves to break apart tissue -- as a method to eliminate cancerous tumors by liquefying them with ultrasound waves. After the sound waves destroy the tumors, the body should eliminate them as cellular waste. When the researchers examined these 'decellularized' tissues, however, they were surprised by what the boiling left intact.
"In some of our experiments, we discovered that some of the stromal tissue and vasculature was being left behind," said Yak-Nam Wang, a senior engineer at the University of Washington's Applied Physics Laboratory. "So we had the idea about using this to decellularize tissues for tissue engineering and regenerative medicine."
The structure that remains after decellularizing tissues is known as the extracellular matrix, a fibrous network that provides a scaffold for cells to grow upon. Most other methods for decellularizing tissues and organs involve chemical and enzymatic treatments that can cause damage to the tissues and fibers and takes multiple days. Histrostipsy, on the other hand, offers the possibility of fast decellularization of tissue with minimal damage to the matrix.
"In tissue engineering, one of the holy grails is to develop biomimetic structures so that you can replace tissues with native tissue," Wang said. Stripping away cells from already developed tissue could provide a good candidate for these structures, since the extracellular matrix already acts as the cellular framework for tissue systems, Wang said.
Due to its bare composition, the matrix also induces only a relatively weak immune response from the host. The matrix could then theoretically be fed with stem cells or cells from the same person to effectively re-grow an organ.
"The other thought is that maybe you could just implant the extracellular matrix and then the body itself would self-seed the tissues, if it's just a small patch of tissue that you're replacing," Wang said. "You won't have any immune issues, and because you have this biomimetic scaffold that's closer to the native tissue, healing would be better, and the body would recognize it as normal tissue."
Wang is currently investigating decellularization of kidney and liver tissue from large animals. Future work involves increasing the size of the decellularized tissues and assessing their in-vivo regenerative efficacy.


Thursday, 16 June 2016

SWEAT EATING BACTERIA MAY IMPROVE SKIN HEALTH




Bacteria that metabolize ammonia, a major component of sweat, may improve skin health and some day could be used for the treatment of skin disorders, such as acne or chronic wounds. In a study conducted by AOBiome LLC, human volunteers using the bacteria reported better skin condition and appearance compared with a placebo control group. The researchers presented the study results at the 5th ASM Conference on Beneficial Microbes in Washington, DC

Ammonia-oxidizing bacteria (AOB) are ubiquitous in soil and water and are essential components of the nitrogen cycle and environmental nitrification processes. The researchers hypothesized that AOB are uniquely suited for the environment of the human skin because ammonia oxidation products, nitrite and nitric oxide, play important roles in physiological functions of the skin, including inflammation, blood vessel relaxation and wound healing. AOB may also improve the skin microenvironment by driving a lower pH through ammonia consumption.
For the study, the researchers used a strain of Nitrosomonas eutropha isolated from organic soil samples. In the blinded, placebo-controlled, study involving 24 volunteers, one group applied a suspension of the live bacteria on their face and scalp for one week, while a second group used placebo. Both groups were followed for an additional two weeks. Subjects did not use hair products during the first and second week and they returned to their normal routine for the third week.
The AOB users reported qualitative improvements in skin condition compared with no or minimal improvement reported by the control group. Use of a bacterial DNA detection assay demonstrated the presence of AOB in 83-100 percent of skin swabs obtained from AOB users during or immediately after completion of the one-week application period, and in 60 percent of the users on Day 14, but not in any of the placebo control samples. Surprisingly, in this small study, the improvement among the AOB users correlated with the levels of AOB on their skin. Neither group had AOB on their skin at the start of the study. Further analysis suggested potential modulation of the skin microbiota by AOB. Importantly, there were no adverse events associated with the topical application of AOB.
"This study shows that live Nitrosomonas are well tolerated and may hold promise as novel, self-regulating topical delivery agents of nitrite and nitric oxide to the human skin," said Dr. Larry Weiss, AOBiome's Chief Medical Officer. "Our next step is to conduct clinical trials to assess the therapeutic potential of AOB in patients with acne or diabetic ulcers."


Wednesday, 15 June 2016

PEOPLE WITH MULTIPLE SCLEROSIS MAY BE AT INCREASED RISK OF DEVELOPING CANCER



Individuals with multiple sclerosis may have an increased risk of developing any type of cancer, with an especially high risk of developing breast cancer. That is the conclusion of a recent study published inEuropean Journal of Neurology. Because the findings contradict earlier studies, additional research is needed to determine whether a true link exists between multiple sclerosis and cancer

Previous research suggests that some individuals with autoimmune diseases may have an increased risk of developing cancer, but most studies have found no link between cancer and multiple sclerosis, an autoimmune disease that involves the central nervous system.

To investigate further, Li-Min Sun, MD, of the Zuoying Branch of Kaohsiung Armed Forces General Hospital in Kaohsiung, Taiwan, and his colleagues assessed data from the National Health Insurance System of Taiwan, including information on 1292 patients who were diagnosed with multiple sclerosis between 1997 and 2010. Each patient was matched with four participants without the condition.
"Our study was a nationwide population-based cohort study, and it revealed unexpected findings," said Dr. Sun. Specifically, the team found that individuals with multiple sclerosis were 85% more likely to develop cancer than the controls. Their risk of developing breast cancer was especially high, with more than a 2-fold increased risk over controls.

The findings suggest that patients with multiple sclerosis patients may need to be monitored closely to ensure early detection of cancer. Dr. Sun notes that it is unclear why his team's results are not consistent with most other studies. "The underlying genetic and environmental factors in Taiwan, which differ from those of western countries, might play an undetermined role. Additional large-scale studies will help improve our understanding," he said.





Saturday, 4 June 2016

A New Book About Neuropathy May Be Worth A Read



Today's post from press.jhu (see link below) is basically a book review via an interview with the author but a very useful one nevertheless. Despite the seeming growth of neuropathy as a 'coffee table topic' and more and more people understanding what happens to millions of people across the world with nerve damage; there are still relatively few good books on the subject available. By good books, I mean books about nerve damage that everybody can relate to without being bogged down by impossible neural science. Dr Janice Wiesman has written 'Peripheral Neuropathy: What It Is and What You Can Do to Feel Better​.' and it seems very promising indeed for the average person who is battling the disease daily. We need objectivity; no hidden commercial agendas and plain well-explained facts that don't try to blind us with science. This book may go some way to providing us with exactly that. Objective, factual information is like gold-dust, so it may be worth while keeping an eye out for this publication.

Q&A with Dr. Janice Wiesman 
Submitted by krm on Tue, 2016-10-25

With her new book coming out soon, Dr. Janice Wiesman has stopped by the JHUP blog to answer a few questions about Peripheral Neuropathy.

Q: Why did you decide to write this book?

For the past 20 years I have been educating patients and families about neuropathy in the office. For the past 10 years I have been speaking at neuropathy support group meetings and patients and families have asked me to make my slides available. So, after 20 years of educating patients and families a few at a time, I decided to listen to my patients and write the book. The last such book written for patients and families was publish in 2006. A lot has changed since then. In addition, I noticed that all of the other books out there on peripheral neuropathy are written by non-physicians: patients, therapists, chiropractors etc. Some of them seen to have a hidden, commercial agenda that I think is not appropriate for a book intending to inform and advise people who have an illness. In addition to providing information regarding neuropathy and a guide through the process of being examined, tested and evaluated in the neurologist’s office, this book is intended to empower patients during their office visit. They have to make sure that the neurologist is explaining things to them to their satisfaction and providing the information and services they need to live the best life possible.

Q: What were some of the most surprising things you learned while writing/researching the book?

It reminded me of what a truly miraculous structure is a nerve cell. A nerve cell, called a neuron, is 50 microns in diameter. That is 50 millionths of a meter. It maintains an arm-like structure that can be up to 3 feet long. That is like a man who is 6 feet tall maintaining an arm that is 20 miles long! This nerve cell and its long arm have to work for 120 years. New nerve cells and nerves are not made; you have to maintain the ones you are born with.

Q: What is new about your book/research that sets it apart from other books in the field?

It is the only up-to-date, consumer-targeted book about neuropathy written by a neurologist on the market. The last such book was published 10 years ago. There has been a lot of progress in the last 10 years in the diagnosis and treatment of neuropathy.

The book walks the reader through the anatomy and function of nerves, the ways that nerves are damaged, decodes the neurological exam, explains common tests and why they are performed, describes treatment with and without medication and ends with a discussion of lifestyle issues that affect, and are affected by, nerve damage.

Q: Did you encounter any eye-opening statistics while writing your book?


It is estimated that 20 million Americans have neuropathy – that is a staggering number. For a third of these people, a cause is not found. While diabetes mellitus is currently the most common cause of neuropathy in the world, until recently, it was leprosy.

Q: Does your book uncover and/or debunk any longstanding myths?


Persons with neuropathy have no barrier to exercise or to a fully satisfying sex life! Neuropathy symptoms are due to damage to the physical structures called nerves and not to “being nervous” or “having nerves”.

Q: What is the single most important fact revealed in your book and why is it significant?

That for many people with neuropathy, the path to symptoms relief is in their own hands. This is particularly true of neuropathy caused by diabetes mellitus and alcohol use. Patients who are empowered to control their illness will be more successful in leading the fullest possible life.

Q: How do you envision the lasting impact of your book?


I hope the book serves as a reference for people with neuropathy and their families. My goal is to educate patients about this one aspect of their own bodies. I hope the book is something they will use to “look up” information about their illness. In addition, I hope it will give them “permission” to question their physicians and make sure all of their questions are answered to their satisfaction.

Q: What do you hope people will take away from reading your book?

I would like patients to know that there is a reason the doctor asks certain questions, performs the physical examination in a certain way and orders certain tests. I want patients to know “what the doctor is thinking’ at each step of the office visit. There is a lot an individual can do to prevent, mitigate and alleviate symptoms of neuropathy. Individuals with neuropathy can lead full and happy lives.

Janice F. Wiesman, MD, FAAN, is an associate clinical professor of neurology at New York University School of Medicine and an adjunct assistant professor of neurology at Boston University School of Medicine. She is the author of Peripheral Neuropathy: What It Is and What You Can Do to Feel Better​.

https://www.press.jhu.edu/news/blog/qa-dr-janice-wiesman